Skip to main content

Table 3 Summary of dose adjustments during the study period

From: Therapeutic drug monitoring of amikacin in septic patients

  Dose administration  
  24 hrs 36 hrs 48 hrs 72 hrs  
Dose management Increased 14 2 4 3 23
  Unchanged 11 3 2 - 16
  Decreased 15 2 4 3 24
   40 7 10 6 63